Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan M Friedman

Showing results (81-90 of 165) with videos related to

Pageof 17
Sort By:
Journal of Neuroscience Research|June 16, 2011
S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromasTracy Tucker, Vincent M Riccardi, Carolyn Brown, et al.
Orphanet Journal of Rare Diseases|April 25, 2018
Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1Laura Sellmer, Said Farschtschi, Marco Marangoni, et al.
Neuro-Oncology|June 19, 2008
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1Victor-F Mautner, Florence A Asuagbor, Eva Dombi, et al.
American Journal of Medical Genetics. Part A|August 21, 2012
Life-history chronicle for a patient with the recently described chromosome 4q21 microdeletion syndromeErica Tsang, Rosemarie Rupps, Barbara McGillivray, et al.
Human Genomics|April 14, 2026
Progranulin genetic variant rs5848 displays ancestry-specific associations with Alzheimer's diseaseBenjamin E Life, Erick I Navarro-Delgado, Oriol Fornes, et al.
Orphanet Journal of Rare Diseases|February 17, 2017
Non-optic glioma in adults and children with neurofibromatosis 1Laura Sellmer, Said Farschtschi, Marco Marangoni, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|November 19, 2010
A different approach to validating screening assays for developmental toxicityGeorge P Daston, Robert E Chapin, Anthony R Scialli, et al.
Journal of Opioid Management|July 14, 2021
Prescription opioid use during pregnancy and risk for preterm birth or term low birthweightJulia D Interrante, Stacey L P Scroggs, Carol J Hogue, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Workforce Implications of Increased Referrals to Hereditary Cancer Services in Canada: A Scenario-Based AnalysisNick Dragojlovic, Kennedy Borle, Nicola Kopac, et al.
Journal of Genetic Counseling|August 19, 2025
Putting control into parents' hands: Parent experiences with a genomic results e-bookletShelin Adam, Patricia Gombas, Michelle Demos, et al.
Pageof 17

Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
Journal of Neuroscience Research|June 16, 2011
S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromasTracy Tucker, Vincent M Riccardi, Carolyn Brown, et al.
Orphanet Journal of Rare Diseases|April 25, 2018
Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1Laura Sellmer, Said Farschtschi, Marco Marangoni, et al.
Neuro-Oncology|June 19, 2008
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1Victor-F Mautner, Florence A Asuagbor, Eva Dombi, et al.
American Journal of Medical Genetics. Part A|August 21, 2012
Life-history chronicle for a patient with the recently described chromosome 4q21 microdeletion syndromeErica Tsang, Rosemarie Rupps, Barbara McGillivray, et al.
Human Genomics|April 14, 2026
Progranulin genetic variant rs5848 displays ancestry-specific associations with Alzheimer's diseaseBenjamin E Life, Erick I Navarro-Delgado, Oriol Fornes, et al.
Orphanet Journal of Rare Diseases|February 17, 2017
Non-optic glioma in adults and children with neurofibromatosis 1Laura Sellmer, Said Farschtschi, Marco Marangoni, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|November 19, 2010
A different approach to validating screening assays for developmental toxicityGeorge P Daston, Robert E Chapin, Anthony R Scialli, et al.
Journal of Opioid Management|July 14, 2021
Prescription opioid use during pregnancy and risk for preterm birth or term low birthweightJulia D Interrante, Stacey L P Scroggs, Carol J Hogue, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Workforce Implications of Increased Referrals to Hereditary Cancer Services in Canada: A Scenario-Based AnalysisNick Dragojlovic, Kennedy Borle, Nicola Kopac, et al.
Journal of Genetic Counseling|August 19, 2025
Putting control into parents' hands: Parent experiences with a genomic results e-bookletShelin Adam, Patricia Gombas, Michelle Demos, et al.
Pageof 17